Evidence map›Paper›PMID 26137231›Full record

ArticleBiomedical reports2015

Association investigation of

Malgorzata Wegner, Adrianna Mostowska, Aleksandra Araszkiewicz, Mahua Choudhury, Maria Piorunska-Stolzmann, Dorota Zozulinska-Ziolkiewicz, Bogna Wierusz-Wysocka, Pawel P Jagodzinski

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Malgorzata WegnerLipid Metabolism Laboratory, Department of General Chemistry, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, Poznan 60-780, Poland.
Adrianna MostowskaDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan 60-781, Poland.
Aleksandra AraszkiewiczDepartment of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan 60-843, Poland.
Mahua ChoudhuryDepartment of Pharmaceutical Sciences, Texas A&M Health Science Center College of Pharmacy, Kingsville 78363, TX, USA.
Maria Piorunska-StolzmannDepartment of Clinical Biochemistry and Laboratory Medicine, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, Poznan 60-780, Poland.
Dorota Zozulinska-ZiolkiewiczDepartment of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan 60-843, Poland.
Bogna Wierusz-WysockaDepartment of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan 60-843, Poland.
Pawel P JagodzinskiDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan 60-781, Poland.
Poznan University of Medical Sciences · PLTexas A&M Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic factors are indicated in the development of type 1 diabetes (DM1). Recently, nucleotide variants of

Indexed as

BACH2 rs3757247 polymorphismSOD2 rs4880 polymorphismtype 1 diabetes

Identifiers

PMID26137231
PMCPMC4461856
OpenAlexW1993062160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.